ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC) represents 10–20% of all breast cancers and is characterized by the absence of the expression of estrogen receptors (ER), progesterone receptors (PR), and the absence of amplification/over-expression of the human epidermal growth factor receptor 2 (HER2) [1].